SCHEMBL4552161

SCHEMBL4552161

O=C(N[C@]1(c2ccccc2)CCCNC1)C1CCC(O)CC1

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 1/20 0.49
SLC6A9 P48067 1/20 0.45
OPRM1 P35372 1/20 0.42
OPRL1 P41146 1/20 0.42
SCN9A Q15858 6/20 0.37
ADORA3 P0DMS8 1/20 0.37
HPGD P15428 2/20 0.36
HSD17B10 Q99714 1/20 0.36
DPP4 P27487 1/20 0.35
HTR2A P28223 1/20 0.35
OPRD1 P41143 1/20 0.34
MAPK8 P45983 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4007365 0.90 SSTR4 (0.54) SSTR4SLC6A9OPRM1OPRL1SCN9A
SCHEMBL4006087 0.90 SSTR4 (0.54) SSTR4SLC6A9OPRM1OPRL1SCN9A
SCHEMBL4007336 0.89 SSTR4 (0.48) SSTR4SLC6A9OPRM1OPRL1SCN9A
SCHEMBL4005570 0.88 SSTR4 (0.49) SSTR4SLC6A9OPRM1OPRL1SCN9A
SCHEMBL4010688 0.87 SSTR4 (0.46) SSTR4SLC6A9OPRM1OPRL1SCN9A
SCHEMBL4004728 0.86 SLC6A9 (0.49) SSTR4SLC6A9OPRM1OPRL1SCN9A
SCHEMBL4004722 0.86 SSTR4 (0.46) SSTR4SLC6A9OPRM1OPRL1SCN9A
SCHEMBL4003526 0.82 SSTR4 (0.45) SSTR4SLC6A9OPRM1OPRL1SCN9A
SCHEMBL7304625 0.80 SSTR4 (0.53) SSTR4OPRM1OPRL1SCN9AHPGD
SCHEMBL4011286 0.80 SLC6A9 (0.50) SSTR4SLC6A9OPRM1HSD17B10HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778229-A4 AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORP (US) 2009-06-17 EP disclosed
EP-1778229-A2 AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS Incyte Corporation (US) 2007-05-02 EP disclosed
WO-2006020598-A2 AMIDO COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2006-02-23 WO disclosed